1-propyl-2-methyl-3-hydroxypyrid-4-one has been researched along with fluorescein in 1 studies
Studies (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Trials (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Recent Studies (post-2010) (1-propyl-2-methyl-3-hydroxypyrid-4-one) | Studies (fluorescein) | Trials (fluorescein) | Recent Studies (post-2010) (fluorescein) |
---|---|---|---|---|---|
8 | 0 | 0 | 6,214 | 283 | 2,082 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aristei, Y; Dirsch, VM; Heiss, EH; Schachner, D; Schmitt, CA; Severin, T | 1 |
1 other study(ies) available for 1-propyl-2-methyl-3-hydroxypyrid-4-one and fluorescein
Article | Year |
---|---|
A Maillard reaction product enhances eNOS activity in human endothelial cells.
Topics: Cardiovascular Diseases; Cell Line; Cells, Cultured; Computational Biology; Endothelial Cells; Expert Systems; Fluorescein; Genes, Reporter; Humans; Indicators and Reagents; Kinetics; Maillard Reaction; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Specificity; Osmolar Concentration; Promoter Regions, Genetic; Pyridones; Up-Regulation | 2010 |